The consequences of the cardiovascular disease-related reductions in CBF include accelerated reduction in frontal, parietal, and temporal grey matter volumes (Moroni et al., 2018), cognitive deficits (Jiang et al., 2023), and increased risk of ADRD (Brain et al., 2023)
[DOI] [PMC free article] [PubMed] [Google Scholar] 111.Baxter R.C., Martin J.L
Standardized dose, long-term safety assessments, and genetic profile stratification (eg, GSTM1 for SFN efficacy) are necessary
Zhuang et al., 2013
But heres some good news in our journey to feeling and looking great: topical GHK-cu peptide products
GHK-Cu : A natural copper-binding tripeptide studied for ECM remodeling pathways in in-vitro fibroblast cultures and animal skin biology models